MEDIROM Healthcare Group Inc (MRM): Market Capitalization-to-Revenue Ratio

Corporate company logo of MEDIROM Healthcare Group Inc (MRM)

MEDIROM is expanding corporate wellness through partner wellness solutions. The primary focus is on the digitalization of spa center management and the creation of smart bracelets for biometric data collection, which eliminates routine data entry. The current P/S valuation on GURU.Markets reflects market expectations, where the value 0.10 describes the current level. Stable demand for medtech innovations provides the company with high cyclicity and resilience.

MRM MEDIROM Healthcare Group Price-to-Revenue Ratio (07/04/2022 - 09/30/2026)

Metric breakdowns and analytics for MEDIROM Healthcare Group Inc (MRM)

- price and consensus price forecast:
Fundamental company analysis:MRM (medirom.co.jp)
Original product of MEDIROM Corp

MEDIROM is transforming its business model, shifting from traditional Japanese relaxation salons to the high-tech wearable biosensor segment. The P/S multiple measures market capitalization relative to annual revenue, determining the value of each dollar of sales. By analyzing the ratio of share price to sales volume, an investor can gauge the balance between the risk of overpayment and growth potential. A decline in this metric may signal either undervalued assets or a slowdown in the expansion of the digital IT division.

Who MEDIROM competes with

Price-to-Revenue Coefficient hcahealthcare.com|Price-to-Revenue Ratio Tenet Healthcare Corporation THC|Market Capitalization-to-Revenue Ratio FMS|SOLV - Price-to-Revenue Ratio|Price to Sales Encompass|uhsinc.com (UHS) - Price-to-Revenue Ratio|Market Cap to Revenue davita.com|Price-to-Revenue Ratio RadNet|Market Cap to Revenue Option Care (OPCH)|Price-to-Revenue Ratio Surgery Partners Corp (SGRY)|PINC (Premier Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio National Vision Holdings EYE|PGNY - Market Cap to Revenue|ARDT: Market Cap to Revenue|Select Medical Corporation - Market Cap to Sales Volume|Apollo Medical Holdings (ASTH) - Price-to-Revenue Ratio|MEDNAX - Market Capitalization-to-Revenue Ratio|USPH (US Physical Therapy) - P/S Multiple|Price to Sales pennantgroup.com PNTG|P/S Multiple ORGO|P/S Multiple Nutex Health Inc (NUTX)|Auna Health - Market Cap to Revenue|Market Cap to Sales Volume SBC (SBC Medical Group Holdings)|EOLS - Price-to-Revenue Ratio|chs.net (CYH) - Market Cap to Revenue|SKIN: P/S Multiple|Price to Sales MediWound (MDWD)|Price-to-Revenue Ratio Biote Corp|Market Cap to Revenue Ratio JYNT (The Joint)|Market Cap to Revenue DCGO (DocGo Inc.)|Market Cap to Sales Volume PIII|Price-to-Revenue Ratio Gain Therapeutics GANX|EUDA - Market Cap to Revenue|Basel Medical Group Limited - P/S Multiple|Price to Sales CollPlant Biotechnologies|CUPR: P/S Multiple|Market Cap to Revenue Ratio CCM|AMS (American Shared Hospital Services) - P/S Multiple|Avalon GloboCare Corporation (ALBT) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|XAGE (Carmell Corp) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Limited NIVF|ATI Physical Therapy Inc. (ATIP) - Price to Sales|CMAX - Price-to-Revenue Ratio|Kindly MD Inc (KDLY) - Market Cap to Revenue|LogistiCare (MODV) - Price-to-Revenue Ratio|Market Cap to Revenue Novo Integrated Sciences Corp|Price-to-Revenue Ratio SunLink Health Systems Inc.|BACK: Market Capitalization-to-Revenue Ratio